Patients infected with either severe acute respiratory syndrome coronavirus (SARS-CoV) or SARS-CoV-2 produce antibodies that bind to the other coronavirus, but the cross-reactive antibodies are not cross protective, at least in cell-culture experiments, researchers report May 17 in the journal Cell Reports. It remains unclear whether such antibodies offer cross protection in the human body or potentiate disease.
- Does genomics perpetuate inequality?
- Drug treatment could improve effectiveness of immunotherapy for cancer patients
- Nurses and midwives take the lead in providing HIV services in Eastern and Southern Africa
- First Alaskan juvenile predator fossil adds insight to dino migration
- Researchers uncover a critical early step of the visual process